Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intermittent vs continuous oral dutasteride regimens for male androgenetic alopecia
TCTR20260329002Phase 4Recruiting
- Sponsor
- Srinakharinwirot University
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dutasteride in androgenetic alopecia (AGA), sponsored by Srinakharinwirot University. Started May 2026; status: recruiting.
02
Drugs
dutasteride
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on TCTR20260329002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260329002.